-
Published 3/3/2025
Beidler LB, Zayhowski K, Nahorniak M, Loo S, Gignac GA, Wang C, Gunn CM. Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer. JCO Oncol Pract. 2025 Mar 03; OP2400624. PMID: 40030090.
-
Published 11/29/2024
Zayhowski K, Wang C, Nahorniak M, Loo S, Gignac G, Gunn C. A qualitative study of the experiences of patients with prostate cancer when receiving negative genetic results: "I still don't have a grasp of what it all means". J Genet Couns. 2024 Nov 29. PMID: 39611226.
-
Published 3/12/2024
Khosla H, Bhatt S, Wang MJ, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. J Oncol Pharm Pract. 2024 Jul; 30(5):941-944. PMID: 38470473.
-
Published 6/29/2023
Gunn CM, Gignac G, Hardy B, Zayhowski K, Pankowska M, Loo S, Wang C. Characterizing Referrals for Prostate Cancer Genetic Services in a Safety-Net Hospital. JCO Oncol Pract. 2023 Oct; 19(10):852-859. PMID: 37384869.
-
Published 1/1/2023
Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care. Cancer Control. 2023; 30:10732748221143884. PMID: 36946278.